Literature DB >> 32239375

Effect of Human Immunodeficiency Virus on Trace Elements in the Brain.

Karen Cilliers1, Christo J F Muller2,3.   

Abstract

Comorbidities of human immunodeficiency virus (HIV) include HIV-associated neurocognitive disorder (HAND). Changes in the brain due to HIV include atrophy, hyperintensities, and diffusion changes. However, no research has focused on trace elements concentration changes in the brain due to HIV, as seen in other neurodegenerative diseases. Therefore, the aim of this study was to determine the concentration of several trace elements in the brains of individuals with and without HIV infection. Prior to formalin embalming, blood was drawn and tested in triplicate with Determine HIV-1/2 rapid tests and confirmed with a SD HIV Device 1/2 3.0 rapid HIV Kit. After embalming, tissue was sampled from the caudate nucleus and analyzed using inductively coupled plasma mass spectrometry. A Kruskal-Wallis test was used to determine statistically significant differences between the two groups (p < 0.05). Fifteen HIV-positive and 14 HIV-negative male cadavers were included (mean age 44, range 22 to 61). Cadmium was marginally decreased, possibly due to malnutrition or utilization by the HIV nucleocapsid. Nickel was marginally increased, perhaps due to a reduced capability to remove metals from the body. In conclusion, this article provides the first information on trace element levels in the brains from HIV-infected individuals and postulates that cadmium and nickel may play a role in the pathophysiology of HAND. This information can contribute to finding a treatment for HAND, other than the use of antiretroviral drugs. Future studies should asses the levels of cadmium and nickel in a larger cohort of HIV-infected individuals.

Entities:  

Keywords:  Brain; Cadmium; Caudate nucleus; HIV-associated neurocognitive disorder; Inductively coupled plasma mass spectrometry; Neurodegeneration; Nickel

Mesh:

Substances:

Year:  2020        PMID: 32239375     DOI: 10.1007/s12011-020-02129-4

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  129 in total

1.  Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's disease.

Authors:  E Andrási; E Farkas; H Scheibler; A Réffy; L Bezúr
Journal:  Arch Gerontol Geriatr       Date:  1995 Jul-Aug       Impact factor: 3.250

2.  Independent effects of HIV, aging, and HAART on brain volumetric measures.

Authors:  Beau M Ances; Mario Ortega; Florin Vaida; Jodi Heaps; Robert Paul
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

3.  HIV-associated neurocognitive disorders: is there a hidden epidemic?

Authors:  Justin C McArthur; Bruce J Brew
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

4.  Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.

Authors:  Sara Cross; Nur Önen; Amber Gase; Edgar Turner Overton; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2013-10-10       Impact factor: 4.147

5.  Cerebral signal intensity abnormalities on T2-weighted MR images in HIV patients with highly active antiretroviral therapy: relationship with clinical parameters and interval changes.

Authors:  Uta Hanning; Ingo W Husstedt; Thomas-Ulrich Niederstadt; Stefan Evers; Walter Heindel; Stephan P Kloska
Journal:  Acad Radiol       Date:  2011-06-23       Impact factor: 3.173

6.  In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.

Authors:  G Bartzokis; D Sultzer; J Mintz; L E Holt; P Marx; C K Phelan; S R Marder
Journal:  Biol Psychiatry       Date:  1994-04-01       Impact factor: 13.382

Review 7.  Interactions between ageing and NeuroAIDS.

Authors:  Joanna Hellmuth; Benedetta Milanini; Victor Valcour
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

8.  Brain Iron and Zinc Contents of German Patients with Alzheimer Disease.

Authors:  Erzsébet Andrási; Eva Farkas; Dieter Gawlik; Ullrich Rösick; Peter Brätter
Journal:  J Alzheimers Dis       Date:  2000-03       Impact factor: 4.472

9.  Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.

Authors:  Kevin Robertson; Carmen Bayon; Jean-Michel Molina; Patricia McNamara; Christiane Resch; Jose A Muñoz-Moreno; Ranjababu Kulasegaram; Knud Schewe; Angel Burgos-Ramirez; Cristina De Alvaro; Esther Cabrero; Matthew Guion; Michael Norton; Jean van Wyk
Journal:  AIDS Care       Date:  2014-07-16

10.  Brain alterations within the first 100 days of HIV infection.

Authors:  Ann B Ragin; Ying Wu; Yi Gao; Sheila Keating; Hongyan Du; Christina Sammet; Casey S Kettering; Leon G Epstein
Journal:  Ann Clin Transl Neurol       Date:  2014-12-18       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.